Treating depression with selective serotonin reuptake inhibitors

A practical approach

Shirlene M. Sampson

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Depression is a common disorder that is becoming better understood as an illness that can be chronic, recurrent, and refractory to treatment. Depression can produce substantial suffering and profoundly affect a patient's self-esteem, relationships, and functional capacity. The improved adverse-effect profile and safety from overdose of selective serotonin reuptake inhibitors (SSRIs) have led to treatment of milder forms of depression and thus increased treatment of depression overall. This article synthesizes several previously published reviews and psychopharmacology resources and addresses practical issues related to initiating, monitoring, continuing, and discontinuing SSRIs. Precautions related to SSRI use and important considerations for various types of depression are discussed.

Original languageEnglish (US)
Pages (from-to)739-744
Number of pages6
JournalMayo Clinic Proceedings
Volume76
Issue number7
StatePublished - 2001

Fingerprint

Serotonin Uptake Inhibitors
Depression
Psychopharmacology
Psychological Stress
Self Concept
Therapeutics
Safety

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Treating depression with selective serotonin reuptake inhibitors : A practical approach. / Sampson, Shirlene M.

In: Mayo Clinic Proceedings, Vol. 76, No. 7, 2001, p. 739-744.

Research output: Contribution to journalArticle

@article{28cc72ba69ab47cbafa66c1f598ef010,
title = "Treating depression with selective serotonin reuptake inhibitors: A practical approach",
abstract = "Depression is a common disorder that is becoming better understood as an illness that can be chronic, recurrent, and refractory to treatment. Depression can produce substantial suffering and profoundly affect a patient's self-esteem, relationships, and functional capacity. The improved adverse-effect profile and safety from overdose of selective serotonin reuptake inhibitors (SSRIs) have led to treatment of milder forms of depression and thus increased treatment of depression overall. This article synthesizes several previously published reviews and psychopharmacology resources and addresses practical issues related to initiating, monitoring, continuing, and discontinuing SSRIs. Precautions related to SSRI use and important considerations for various types of depression are discussed.",
author = "Sampson, {Shirlene M.}",
year = "2001",
language = "English (US)",
volume = "76",
pages = "739--744",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "7",

}

TY - JOUR

T1 - Treating depression with selective serotonin reuptake inhibitors

T2 - A practical approach

AU - Sampson, Shirlene M.

PY - 2001

Y1 - 2001

N2 - Depression is a common disorder that is becoming better understood as an illness that can be chronic, recurrent, and refractory to treatment. Depression can produce substantial suffering and profoundly affect a patient's self-esteem, relationships, and functional capacity. The improved adverse-effect profile and safety from overdose of selective serotonin reuptake inhibitors (SSRIs) have led to treatment of milder forms of depression and thus increased treatment of depression overall. This article synthesizes several previously published reviews and psychopharmacology resources and addresses practical issues related to initiating, monitoring, continuing, and discontinuing SSRIs. Precautions related to SSRI use and important considerations for various types of depression are discussed.

AB - Depression is a common disorder that is becoming better understood as an illness that can be chronic, recurrent, and refractory to treatment. Depression can produce substantial suffering and profoundly affect a patient's self-esteem, relationships, and functional capacity. The improved adverse-effect profile and safety from overdose of selective serotonin reuptake inhibitors (SSRIs) have led to treatment of milder forms of depression and thus increased treatment of depression overall. This article synthesizes several previously published reviews and psychopharmacology resources and addresses practical issues related to initiating, monitoring, continuing, and discontinuing SSRIs. Precautions related to SSRI use and important considerations for various types of depression are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0034961677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034961677&partnerID=8YFLogxK

M3 - Article

VL - 76

SP - 739

EP - 744

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 7

ER -